National income, self-reported wheezing and asthma diagnosis from the World Health Survey
National income, self-reported wheezing and asthma diagnosis from the World Health Survey
复制标题
DOI：
10.1183/09031936.00027509
复制
发表时间：
2010-02-01
影响因子：
24.3
通讯作者：
Punnett, L.
中科院分区：
文献类型：
--
作者：
Sembajwe, G.;Cifuentes, M.;Punnett, L.
这项研究的目的是量化和描述的变化，呼吸道症状和诊断患病率在世界各地区根据national income.In 2002年和2003年，世界卫生组织实施了世界卫生调查（WHS），其中使用了一个标准化的调查工具，以汇编全面的基线信息的健康和医疗保健支出。我们分析了WHS数据，以评估自我报告的喘息和医生诊断的哮喘的全球模式，这是两种常见的呼吸系统健康指标。共有来自64个国家的308，218名参与者有完整的记录。调查人群的加权平均年龄为43岁。当前喘息症状的全球患病率范围从越南的2.4%到巴西的24%;确诊哮喘的患病率范围从越南的1.8%到澳大利亚的32.8%。总体而言，症状和诊断的流行率呈U形模式，低收入和高收入国家报告的流行率最高。这些WHS分析使用六大洲同时和一致收集的数据提供了喘息和医生诊断的哮喘的全球患病率估计。这些发现支持了持续进行全球呼吸道疾病监测的必要性，以用于疾病预防、卫生政策和管理。
The aims of this study were to quantify and describe the variations in respiratory symptoms and diagnosis prevalence across regions of the world according to national income.In 2002 and 2003, the World Health Organization implemented the World Health Survey (WHS), which used a standardised survey instrument to compile comprehensive baseline information on health and healthcare expenditure. We analysed the WHS data to assess the global patterns of self-reported wheeze and doctor-diagnosed asthma, two commonly reported measures of respiratory health.In total there were 308,218 participants with complete records, from 64 countries. The weighted mean age of the survey population was 43 yrs. Global prevalence of current wheezing symptoms ranged from 2.4% in Vietnam to 24% in Brazil; the prevalence of diagnosed asthma ranged from 1.8% in Vietnam to 32.8% in Australia. Overall, the prevalence of symptoms and diagnosis showed a U-shaped pattern with the largest prevalence reported in low- and high-income countries. The smallest prevalence was consistently found in middle-income countries.These WHS analyses have provided global prevalence estimates of wheeze and doctor-diagnosed asthma using data gathered simultaneously and consistently across six continents. These findings support the need for continued global respiratory illness surveillance for disease prevention, health policy and management.